297 related articles for article (PubMed ID: 33462367)
1. Papillary neoplasms of the breast-reviewing the spectrum.
Tay TKY; Tan PH
Mod Pathol; 2021 Jun; 34(6):1044-1061. PubMed ID: 33462367
[TBL] [Abstract][Full Text] [Related]
2. Papillary lesions of the breast.
Kulka J; Madaras L; Floris G; Lax SF
Virchows Arch; 2022 Jan; 480(1):65-84. PubMed ID: 34734332
[TBL] [Abstract][Full Text] [Related]
3. Papillary lesions of the breast - review and practical issues.
Ni Y; Tse GM
Semin Diagn Pathol; 2022 Sep; 39(5):344-354. PubMed ID: 35718581
[TBL] [Abstract][Full Text] [Related]
4. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
Purcell CA; Norris HJ
Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
[TBL] [Abstract][Full Text] [Related]
5. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
6. Pathological criteria and practical issues in papillary lesions of the breast - a review.
Ni YB; Tse GM
Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
[No Abstract] [Full Text] [Related]
8. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
[TBL] [Abstract][Full Text] [Related]
9. Papillary lesions of the breast.
Ibarra JA
Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
[TBL] [Abstract][Full Text] [Related]
10. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
11. Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
[TBL] [Abstract][Full Text] [Related]
12. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Papillary Breast Lesions on Core Needle Biopsy: Upgrade Rates and Interobserver Variability.
Qiu L; Mais DD; Nicolas M; Nanyes J; Kist K; Nazarullah A
Int J Surg Pathol; 2019 Oct; 27(7):736-743. PubMed ID: 31187678
[TBL] [Abstract][Full Text] [Related]
14. Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology?
Michael CW; Buschmann B
Cancer; 2002 Apr; 96(2):92-100. PubMed ID: 11954026
[TBL] [Abstract][Full Text] [Related]
15. A case of male breast encapsulated papillary carcinoma with ductal carcinoma in situ and invasive ductal carcinoma.
Hong F; Li N; Feng Z; Zhang F
Asian J Surg; 2023 Sep; 46(9):3777-3778. PubMed ID: 36990811
[No Abstract] [Full Text] [Related]
16. Papillary carcinoma of the breast: diagnostic agreement and management implications.
Rakha EA; Ahmed MA; Ellis IO
Histopathology; 2016 Nov; 69(5):862-870. PubMed ID: 27270947
[TBL] [Abstract][Full Text] [Related]
17. Composite encapsulated papillary carcinoma and solid papillary carcinoma.
Cui X; Wei S
Pathol Int; 2015 Mar; 65(3):133-7. PubMed ID: 25545718
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast.
Hashmi AA; Faraz M; Rafique S; Adil H; Imran A
Cureus; 2020 Oct; 12(10):e11026. PubMed ID: 33214954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
